Insights

Gathering insights about Climb…

Similar companies to Climb

Climb Tech Stack

Climb uses 8 technology products and services including Adobe, Power BI, React, and more. Explore Climb's tech stack below.

Adobe
Audio, Video, Graphics
Power BI
Business Intelligence
React
Javascript Frameworks
Visual Basic .NET
Programming
Ruby
Programming Languages
Node.js
Programming Languages
Cypress.io
Testing And Qa
Material UI
UI Frameworks

Media & News

Why Is Climb Bio Stock Gaining Friday?
Climb Bio Inc. (NASDAQ:CLYM) on Thursday shared initial data from its ongoing Phase 1b portion of its Phase 1b/2a study of budoprutug for primary immune thrombocytopenia (ITP), an autoimmune disorder where the immune system mistakenly attacks and destroys platelets.
Jun 12, 2026 | www.benzinga.com
Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026
Data demonstrate favorable safety and tolerability profile, robust B-cell depletion, and encouraging platelet responses in heavily pretreated patients with primary immune thrombocytopenia Enrollment ongoing in the high dose cohort, with additional data anticipated by year-end 2026 WELLESLEY HILLS, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced initial data from the ongoing Phase 1b portion of its Phase 1b/2a study evaluating budoprutug, an anti-CD19 monoclonal antibody, in adults with primary immune thrombocytopenia (ITP) demonstrating an encouraging safety and tolerability profile, robust B-cell depletion, and meaningful platelet responses in heavily pretreated patients.
Jun 11, 2026 | www.globenewswire.com
Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development
Company to share additional CLYM116 clinical data and plans for further development at R&D Spotlight in late summer
Jun 05, 2026 | www.globenewswire.com
Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026
WELLESLEY HILLS, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced upcoming presentations for its CLYM116 and budoprutug programs at the European Renal Association Congress 2026, which will be held in Glasgow, Scotland June 3-6, 2026.
May 26, 2026 | www.globenewswire.com
Climb Bio Teases Key Budoprutug, CLYM116 Readouts at BioConnect
Climb Bio NASDAQ: CLYM outlined its clinical development strategy and upcoming data readouts during a fireside chat at H.C. Wainwright's BioConnect Conference, with management emphasizing two biologic drug programs aimed at immune-mediated diseases, including nephrology and hematology indications.
May 21, 2026 | www.marketbeat.com
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
WELLESLEY HILLS, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced an upcoming presentation on its budoprutug program at the European Hematology Association (EHA) 2026 Congress, which will be held in Stockholm, Sweden June 11-14, 2026.
May 14, 2026 | www.globenewswire.com
Climb Bio to Present at Upcoming Investor Conferences
WELLESLEY HILLS, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that members of its executive team will participate in the upcoming conferences detailed below.
May 12, 2026 | www.globenewswire.com

Climb's Email Address Formats

Climb uses at least 2 format(s):

Climb Email Formats	Example	Percentage
First@tacotax.fr	John@tacotax.fr	50%
First.Last@tacotax.fr	John.Doe@tacotax.fr	34%
Last@tacotax.fr	Doe@tacotax.fr	13%
First.Middle@tacotax.fr	John.Michael@tacotax.fr	3%
First.Last@climb.fr	John.Doe@climb.fr	100%

Frequently Asked Questions

Where is Climb's headquarters located?

Climb's main headquarters is located at 3 Rue D'héliopolis Paris, Île-de-france 75017 France. The company has employees across 5 continents, including EuropeNorth AmericaSouth America.

What is Climb's stock symbol?

Climb is a publicly traded company; the company's stock symbol is CLYM.

What is Climb's official website and social media links?

Climb's official website is climb.fr and has social profiles on LinkedIn.

What is Climb's NAICS code?

Climb's NAICS code is 52 - Finance and Insurance.

How many employees does Climb have currently?

As of May 2026, Climb has approximately 67 employees across 5 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Of Staff: J. J.Head Of Product & Ops: M. C.Co-Fondateur & Ceo: A. E.. Explore Climb's employee directory with LeadIQ.

What industry does Climb belong to?

Climb operates in the Financial Services industry.

What technology does Climb use?

Climb's tech stack includes AdobePower BIReactVisual Basic .NETRubyNode.jsCypress.ioMaterial UI.

What is Climb's email format?

Climb's email format typically follows the pattern of First@tacotax.fr. Find more Climb email formats with LeadIQ.

When was Climb founded?

Climb was founded in 2016.

Climb

Q: What is Climb's official website and social media links?

Climb's official website is climb.fr. Climb has social profiles on LinkedIn.

Q: How many employees does Climb have currently?

Climb has approximately 67 employees.

Q: What technology does Climb use?

Climb's tech stack includes DoubleClick Floodlight, Ruby, jQuery, OVHcloud, Axeptio.

Q: What is Climb's NAICS code?

Climb's NAICS code is 52 (Finance and Insurance).

Financial ServicesÎle-de-france, France51-200 Employees

Climb is a financial services firm based in Paris, Île-de-France, focused on helping individuals manage their patrimony, investments, and taxes. By pairing the expertise of financial advisors with digital tools, it seeks to deliver a smoother, more accessible user experience. Its investment offering is presented as independent and designed with a flexible structure intended to support performance. Tax optimization is supported by experts and online tools, with fees described as reduced and transparent relative to traditional banks. Overall, the company seeks to make wealth management more responsive and transparent in the French market.